Sanare A.S. identifies medicines from living multicellular organisms. The trigger is a method of treatment using a non-invasive technique, and the tools are modern biotechnology methods. Sanare does not perform research in making the medicines from chemical artifical compounds, but lets the body do the work in finding a potential remedy to a disease.  Through research on bioactive oligopeptides, and the trillions of combinations in sequences, Sanare has patented a method of identifying the ideal ones. No complex thinking, no confusing science, just plain and simple translation of healing-effects to a tube.

 

 

   

Recent developments

What is Sanare's activity? Are you in a hurry or looking for a brief explanation of Sanare's activity? Read more...

November 2009: Full studies from Charles River Laboratories, Ann Arbor.
October 2009: International patent survey successful. PCT patenting process to start in 2010. Read more...
 
 
Ongoing Research
- "Identification of twelve non-toxic oligopeptides with cytostatic effects on three breast cancer cell lines."  Read More...

 

 

Copyright © 2007-2008 Sanare A.S.
Sanare A.S. Tinghaugveien 435, 3175 Ramnes. Norway.  Org. nr. 991489029 
Tel: +47 9132 7347 Fax: +47 3339 7855